Affiliation:
1. Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland, Canada
2. Eastern Health Region, St. John’s, Newfoundland, Canada
Abstract
Background: Late diagnosis of HIV is associated with poor outcomes and increased cost. Novel HIV testing promotion strategies may reduce late diagnosis. The purpose of this study was to determine the timeliness of HIV testing in Newfoundland and Labrador (NL), missed opportunities for testing, and barriers to HIV testing. Methods: Demographic and clinical information from individuals diagnosed with HIV in NL from 2006–2016 was retrospectively reviewed. Patients were also invited to participate in semi-structured interviews regarding knowledge about HIV transmission, risk associated with their behaviour, testing decision making, and testing opportunities. Results: Fifty-eight new HIV diagnoses occurred during the study period: 53/58 (91.4%) were male and 33/58 (56.9%) were men who have sex with men. The mean age at diagnosis was 40.6 (SD 11.05) years. CD4 count at diagnosis ranged from 2 to 1,408 cells/mm3, with a mean of 387 cells/mm3. For 39/58 (67.2%) of individuals, the first-ever HIV test was positive. Of the 58 patients, 55 (94.8%) had had health care contact within the 5 years prior to diagnosis (mean 13.7 contacts). Heterosexual men were more likely to present with a late diagnosis ( p = 0.049). Ten (17.2%) individuals agreed to an interview. Thematic analysis revealed that barriers to testing were stigma, negative health care interactions, denial, and fear of the diagnosis. Conclusions: HIV diagnosis is made later in NL than in other Canadian provinces. Late diagnosis may be prevented if HIV testing became a routine testing procedure.
Publisher
University of Toronto Press Inc. (UTPress)
Subject
Infectious Diseases,Microbiology (medical)
Reference33 articles.
1. 1. Public Health Agency of Canada. Summary: measuring Canada’s progress on the 90-90-90 HIV targets. Ottawa: Government of Canada; 2016 [updated 2017 Apr 12; cited 2018 Nov 21]. Available from: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/summary-measuring-canada-progress-90-90-90-hiv-targets.html.
2. Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United States
3. Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor–Naive HIV-Infected Patients
4. Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays — United States
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献